Meta-analysis of the Efficacy and Tolerability of Immune Checkpoint Inhibitors Combined With Chemotherapy in First-line Treatment of Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Meta-analysis of the Efficacy and Tolerability of Immune Checkpoint Inhibitors Combined With Chemotherapy in First-line Treatment of Small Cell Lung Cancer

Published:2021-03 Issue:3 Volume:43 Page:582-593.e2
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Wu Jiao,Zhang Aifen,Li Lu,Liu Sicheng,Yang Fang,Yang Runxiang^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference36 articles.

1. Small-cell lung cancer: what we know, what we need to know and the path forward;Gazdar;Nat Rev Cancer,2017

2. The international association for the study of lung cancer lung cancer staging project: proposals for the revision of the clinical and pathologic staging of small cell lung cancer in the forthcoming eighth edition of the TNM classification for lung cancer;Nicholson;J Thorac Oncol,2016

3. Survival changes in patients with small cell lung cancer and disparities between different sexes, socioeconomic statuses and ages;Wang;Sci Rep,2017

4. Small-cell lung cancer: prognostic factors and changing treatment over 15 years;Gaspar;Clin Lung Cancer,2012

5. Current standards for clinical management of small cell lung cancer;Farago;Transl Lung Cancer Res,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating first-line therapies for extensive-stage small-cell lung cancer: a frequentist network meta-analysis and systematic review;Future Oncology;2024-07-29

2. Epigenetic drugs as new emerging therapeutics: What is the scale's orientation of application and challenges?;Pathology - Research and Practice;2023-08

3. Long-term survival in extensive-stage small-cell lung cancer treated with different immune checkpoint inhibitors in multiple-line therapies: A case report and literature review;Frontiers in Immunology;2022-11-30

4. Immune checkpoint inhibitors in the first-line treatment of metastatic small-cell lung cancer;Oncology in Clinical Practice;2022-04-29

5. Risk Factors of Cytomegalovirus Reactivation in Ulcerative Colitis Patients: A Meta-Analysis;Diagnostics;2021-10-21